查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2151670

細胞治療自動化細胞處理系統市場：全球市場預測，2026-2032年

Automated Cell Processing Systems for Cell Therapy Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，用於細胞治療的自動化細胞處理系統的市場規模將達到 32.8 億美元，複合年成長率為 8.77%。

主要市場統計數據
基準年 2025 18.2億美元
預計年份：2026年 19.6億美元
預測年份 2032 32.8億美元
複合年成長率 (%) 8.77%

用於細胞治療的自動化細胞處理系統：概述

自動化細胞處理系統透過將細胞分選、洗滌、濃縮、活化、培養、配製和裝載等任務整合到受控的工作流程中，在細胞療法的開發和生產中發揮核心作用。其策略價值在於提高製程一致性、減少人工勞動、增強可追溯性，並支援封閉式或功能性封閉式操作。實施的可行性取決於臨床階段的要求、生產準備、監管預期、設施設計、員工能力以及與不同細胞類型和治療方案的兼容性。

自動化正在徹底改變細胞療法的生產流程。

當前情勢正從依賴人工操作的繁瑣流程轉向標準化、數位化記錄且日益模組化的流程。開發人員和製造商優先考慮能夠支援無菌加工、一次性耗材、電子批次記錄、進程內監控和可重複參數控制的系統。隨著企業對更嚴格的「身分鏈」和「監管鏈」管理的需求日益成長，與品質系統和製造執行平台的整合也變得愈發重要。同時，設備的柔軟性仍然至關重要，因為每種工作流程——自體、異體細胞、免疫細胞、幹細胞和基因修飾細胞——對加工能力、污染控制和製程控制的要求各不相同。

利用人工智慧 (AI) 增強過程控制和決策支持

人工智慧 (AI) 透過模式識別、異常檢測、預測性維護、基於影像的評估和程式參數最佳化，為細胞加工操作做出貢獻。透過整合感測器數據和歷史批次記錄，AI 工具能夠及早識別偏差，並在培養、生長和配方等各個階段支持更一致的決策。有效利用 AI 需要數據品質、檢驗的演算法、可解釋性、網路安全以及清晰的人工監督。監管部門的批准需要提供模型性能、變更管理方面的文檔，以及證明 AI 驅動的決策不會損害產品品質或病人安全的證據。

區域趨勢反映了製造業和監管重點的差異。

北美地區的特點是先進細胞療法的開發、完善的生物製程基礎設施以及對可擴展且符合規範的自動化技術的強勁需求。歐洲則著重於統一的品質標準、跨境生產協調以及與先進醫療產品（ATMP）框架的整合。亞太地區兼具快速的臨床開發、不斷擴大的生產能力以及各市場監管成熟度不一的特點。拉丁美洲正透過專業中心、技術轉移和夥伴關係來推進能力建設，以解決基礎設施和人力資源的限制。中東地區的醫療現代化和對本土先進治療能力的投資正在穩步推進，而非洲的進展則集中在關鍵的醫療和研究中心，准入、資金籌措和技術培訓仍然是至關重要的考量。

針對不同的經濟和政策群體，將會揭示不同的實施條件。

在東協市場，細胞治療能力建構進展不均衡，互操作系統、訓練和服務支援尤為重要。金磚國家擁有強大的科學研究實力，但監管、基礎設施和在地化要求各不相同。歐盟雖然受益於通用的法律規範，但在報銷、採購和設施部署方面仍存在國家差異。七國集團普遍高度重視驗證、資料完整性、自動化成熟度和彈性供應鏈。海灣合作理事會成員國支持先進的醫療基礎設施和集中式專科醫療服務，而北約成員國則日益關注可靠的生物醫學供應鏈、軍民兩用生產的韌性以及跨境研究合作。

各國具體優先事項涵蓋規模、法規和技術準備。

美國和加拿大擁有先進的臨床生態系統，並迫切需要擴充性、合規且數位化整合的流程。德國、法國、義大利、西班牙和英國強調嚴格的品質系統、專業化的製造以及與臨床應用和監管要求的契合。澳洲正在建立以研究機構和專業製造中心為核心的先進治療能力。中國、日本、韓國和印度正在擴大國內細胞療法的研究和生產，同時推動在地化、驗證並滿足人力資源需求。巴西和墨西哥正透過學術機構、醫院和產業界的合作來加強區域能力。俄羅斯的發展環境則受到國內基礎設施、監管變化和供應鏈因素的影響。

產業領導者應該建立柔軟性、經過驗證且數據就緒的平台。

領導者應選擇能夠處理多種治療方案且不會為驗證和變更管理帶來不必要複雜性的自動化架構。優先事項應包括將關鍵品質屬性 (CQA) 對應到自動化程式參數、實施穩健的身份鏈管理、合格一次性元件以及設計電子記錄以確保可審計性。組織還應制定分階段的技術轉移計劃，投資培訓操作人員和品管負責人，並評估全部區域的營運可行性。人工智慧計畫應從明確定義的用例、受控資料集、獨立檢驗和人工審核開始。如果明確界定責任、資料所有權和監管課責，與臨床中心、契約製造和技術提供者夥伴關係可以降低部署風險。

調查方法。

本執行摘要系統地調查了目前用於細胞治療的自動化細胞處理系統的現狀。分析涵蓋工作流程能力、治療方法、自動化架構、品質和監管要求、數位化整合、區域背景、經濟群體以及國家層面的採用因素。分析結果整合了公開檢驗的監管文件、同行評審的研究、技術文獻、臨床開發資訊以及已記錄的生產實踐。本評估為定性且具指示性，有意排除市場估算和預測、市場規模計算、市場佔有率、預測以及未經證實的公司特定聲明。

自動化將是實現可重複細胞療法的核心要素。

在細胞療法從專業實驗室流程轉型為可重複、可控且可擴展的生產模式過程中，自動化細胞處理系統的重要性日益凸顯。最具潛力的平台應具備流程柔軟性、封閉式操作、電子可追溯性、檢驗的分析方法以及與現有設施的實際整合等優勢。由於地區和國家差異，部署策略必須根據當地的基礎設施、法規、勞動力和供應鏈狀況量身定做。那些秉持「品質源自於設計 (QbD)」原則並採用嚴格的數位化管治來推動自動化的機構，將更有能力提高一致性，並滿足臨床和商業性細胞療法生產中不斷變化的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 細胞治療自動化細胞處理系統市場：依組件類型分類

  • 配件
  • 消耗品
    • 試劑盒和墨盒
    • 試劑
      • 培養基
      • 細胞激素
      • 生長因子
  • 裝置
    • 細胞增殖系統
    • 細胞處理工作站
    • 細胞分選系統
      • 流式細胞技術
      • 磁珠
      • 微流體
    • 細胞洗滌和濃縮系統
  • 服務
  • 軟體

第8章：細胞治療自動化細胞處理系統市場：依細胞類型分類

  • 樹突狀細胞
  • NK細胞
  • 幹細胞
  • T細胞

第9章：細胞治療自動化細胞處理系統市場：依工作流程階段分類

  • 細胞增殖
  • 細胞分選
  • 冷凍保存/儲存
  • 配方、填充和成品
  • 洗滌和濃縮

第10章：細胞治療自動化細胞處理系統市場：依技術分類

  • 封閉式系統
  • 開放系統

第11章：細胞治療自動化細胞處理系統市場：依應用領域分類

  • 同種異體移植療法
  • 自體療法

第12章 細胞治療自動化細胞處理系統市場：依最終使用者分類

  • 學術研究機構
  • 契約製造組織
  • 醫院和診所
  • 製藥和生物技術公司

第13章：細胞治療自動化細胞處理系統市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：細胞治療自動化細胞處理系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：細胞治療自動化細胞處理系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • BD Biosciences
  • BioSpherix, LLC
  • Cellares Inc.
  • CellGenix GmbH
  • Cook Regentec LLC
  • Danaher Corporation
  • Fresenius Kabi AG
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • PALL Corporation
  • Sartorius AG
  • Showa Denko Materials Co., Ltd.
  • STEMCELL Technologies Inc.
  • Takara Bio Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.

第18章 主要專家

Product Code: MRR-537DB9F44AE2

The Automated Cell Processing Systems for Cell Therapy Market is projected to grow by USD 3.28 billion at a CAGR of 8.77% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.82 billion
Estimated Year [2026] USD 1.96 billion
Forecast Year [2032] USD 3.28 billion
CAGR (%) 8.77%

Automated Cell Processing Systems for Cell Therapy: Executive Overview

Automated cell processing systems are becoming central to the development and manufacture of cell therapies by integrating tasks such as cell selection, washing, concentration, activation, culture, formulation, and filling into controlled workflows. Their strategic value lies in improving process consistency, reducing manual interventions, strengthening traceability, and supporting closed or functionally closed operations. Adoption is shaped by clinical-stage requirements, manufacturing readiness, regulatory expectations, facility design, workforce capabilities, and compatibility with diverse cell types and therapy protocols.

Automation Is Reshaping Cell-Therapy Manufacturing Workflows

The landscape is shifting from highly manual, operator-dependent procedures toward standardized, digitally documented, and increasingly modular processing. Developers and manufacturers are prioritizing systems that can support aseptic handling, single-use consumables, electronic batch records, in-process monitoring, and reproducible parameter control. Integration with quality systems and manufacturing execution platforms is becoming more important as organizations seek stronger chain-of-identity and chain-of-custody management. At the same time, equipment flexibility remains essential because autologous, allogeneic, immune-cell, stem-cell, and gene-modified workflows impose different requirements for throughput, contamination control, and process control.

Artificial Intelligence Strengthens Process Control and Decision Support

Artificial intelligence is contributing to cell-processing operations through pattern recognition, anomaly detection, predictive maintenance, image-based assessment, and optimization of process parameters. When linked with sensor data and historical batch records, AI tools can help identify deviations earlier and support more consistent decisions during culture, expansion, and formulation. Their effective use depends on data quality, validated algorithms, explainability, cybersecurity, and clear human oversight. Regulatory acceptance will require documented model performance, change control, and evidence that AI-assisted decisions do not compromise product quality or patient safety.

Regional Dynamics Reflect Different Manufacturing and Regulatory Priorities

North America is characterized by advanced cell-therapy development, established bioprocessing infrastructure, and strong demand for scalable, compliant automation. Europe emphasizes harmonized quality expectations, cross-border manufacturing coordination, and integration with advanced therapy medicinal-product frameworks. Asia-Pacific combines rapid clinical development, expanding manufacturing capacity, and varied regulatory maturity across markets. Latin America is building capability through specialist centers, technology transfer, and partnerships that address infrastructure and workforce constraints. The Middle East is investing in healthcare modernization and localized advanced-therapy capacity, while Africa's progress is concentrated in leading medical and research hubs, with access, funding, and technical training remaining important considerations.

Economic and Policy Groups Reveal Distinct Adoption Conditions

ASEAN markets are developing cell-therapy capabilities unevenly, making interoperable systems, training, and service support particularly valuable. BRICS economies combine substantial scientific capacity with diverse regulatory, infrastructure, and localization requirements. The European Union benefits from common regulatory structures while retaining national differences in reimbursement, procurement, and facility implementation. G7 countries generally place strong emphasis on validation, data integrity, automation maturity, and resilient supply chains. GCC countries are supporting advanced healthcare infrastructure and centralized specialist services, whereas NATO members show increasing interest in dependable biomedical supply chains, dual-use manufacturing resilience, and cross-border research collaboration.

Country-Level Priorities Span Scale, Regulation, and Technical Readiness

The United States and Canada combine advanced clinical ecosystems with demand for scalable, compliant, and digitally integrated processing. Germany, France, Italy, Spain, and the United Kingdom emphasize rigorous quality systems, specialized manufacturing, and alignment between clinical translation and regulatory requirements. Australia is developing advanced-therapy capability around research institutions and specialist production centers. China, Japan, South Korea, and India are expanding domestic cell-therapy research and manufacturing while addressing localization, validation, and workforce needs. Brazil and Mexico are strengthening regional capacity through academic, hospital, and industrial collaboration. Russia's development environment is influenced by domestic infrastructure, regulatory evolution, and supply-chain considerations.

Industry Leaders Should Build Flexible, Validated, and Data-Ready Platforms

Leaders should select automation architectures that can accommodate multiple therapy modalities without creating unnecessary complexity in validation or change control. Priority actions include mapping critical quality attributes to automated process parameters, implementing robust chain-of-identity controls, qualifying single-use assemblies, and designing electronic records for auditability. Organizations should also establish staged technology-transfer plans, invest in operator and quality training, and assess serviceability across target regions. AI initiatives should begin with well-defined use cases, governed datasets, independent validation, and human review. Partnerships with clinical centers, contract manufacturers, and technology providers can reduce implementation risk when responsibilities, data ownership, and regulatory accountability are clearly defined.

Methodology Combines Structured Market Review With Application and Geography Analysis

This executive summary uses a structured review of the automated cell-processing systems landscape for cell therapy. The analysis considers workflow functions, therapy modalities, automation architectures, quality and regulatory requirements, digital integration, regional conditions, economic groupings, and country-level adoption factors. Insights are synthesized from publicly verifiable regulatory materials, peer-reviewed research, technical literature, clinical-development information, and documented manufacturing practices. The assessment is qualitative and directional; it intentionally excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Automation Will Be a Core Enabler of Reproducible Cell-Therapy Delivery

Automated cell processing systems are increasingly important to the transition of cell therapy from specialized laboratory procedures toward repeatable, controlled, and scalable manufacturing. The strongest opportunities are associated with platforms that combine process flexibility, closed handling, electronic traceability, validated analytics, and practical integration with existing facilities. Regional and country differences mean that adoption strategies must be tailored to infrastructure, regulation, workforce, and supply-chain conditions. Organizations that align automation with quality-by-design principles and disciplined digital governance will be better positioned to improve consistency while supporting the evolving requirements of clinical and commercial cell-therapy production.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Automated Cell Processing Systems for Cell Therapy Market, by Component Type

  • 7.1. Introduction
  • 7.2. Accessories
  • 7.3. Consumables
    • 7.3.1. Kits & Cartridges
    • 7.3.2. Reagents
      • 7.3.2.1. Culture Media
      • 7.3.2.2. Cytokines
      • 7.3.2.3. Growth Factors
  • 7.4. Instruments
    • 7.4.1. Cell Expansion Systems
    • 7.4.2. Cell Processing Workstations
    • 7.4.3. Cell Selection Systems
      • 7.4.3.1. Flow Cytometry
      • 7.4.3.2. Magnetic Bead
      • 7.4.3.3. Microfluidic
    • 7.4.4. Cell Washing & Concentration Systems
  • 7.5. Services
  • 7.6. Software

8. Automated Cell Processing Systems for Cell Therapy Market, by Cell Type

  • 8.1. Introduction
  • 8.2. Dendritic Cells
  • 8.3. NK Cells
  • 8.4. Stem Cells
  • 8.5. T Cells

9. Automated Cell Processing Systems for Cell Therapy Market, by Workflow Stage

  • 9.1. Introduction
  • 9.2. Cell Expansion
  • 9.3. Cell Selection
  • 9.4. Cryopreservation & Storage
  • 9.5. Formulation & Fill-Finish
  • 9.6. Washing & Concentration

10. Automated Cell Processing Systems for Cell Therapy Market, by Technology

  • 10.1. Introduction
  • 10.2. Closed Systems
  • 10.3. Open Systems

11. Automated Cell Processing Systems for Cell Therapy Market, by Application

  • 11.1. Introduction
  • 11.2. Allogeneic Therapy
  • 11.3. Autologous Therapy

12. Automated Cell Processing Systems for Cell Therapy Market, by End User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
  • 12.3. Contract Manufacturing Organizations
  • 12.4. Hospitals & Clinics
  • 12.5. Pharmaceutical & Biotech Companies

13. Automated Cell Processing Systems for Cell Therapy Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Automated Cell Processing Systems for Cell Therapy Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Automated Cell Processing Systems for Cell Therapy Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. BD Biosciences
  • 17.2. BioSpherix, LLC
  • 17.3. Cellares Inc.
  • 17.4. CellGenix GmbH
  • 17.5. Cook Regentec LLC
  • 17.6. Danaher Corporation
  • 17.7. Fresenius Kabi AG
  • 17.8. Lonza Group AG
  • 17.9. Merck KGaA
  • 17.10. Miltenyi Biotec GmbH
  • 17.11. PALL Corporation
  • 17.12. Sartorius AG
  • 17.13. Showa Denko Materials Co., Ltd.
  • 17.14. STEMCELL Technologies Inc.
  • 17.15. Takara Bio Inc.
  • 17.16. Terumo Corporation
  • 17.17. Thermo Fisher Scientific Inc.

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Automated Cell Processing Systems for Cell Therapy Market, Years Considered for the Study
  • FIGURE 2. Global Automated Cell Processing Systems for Cell Therapy Market, Research Design
  • FIGURE 3. Global Automated Cell Processing Systems for Cell Therapy Market, Research Framework
  • FIGURE 4. Global Automated Cell Processing Systems for Cell Therapy Market, Data Triangulation
  • FIGURE 5. Global Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2025 vs 2032 (%)
  • FIGURE 11. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 13. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 15. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 17. Global Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Automated Cell Processing Systems for Cell Therapy Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Automated Cell Processing Systems for Cell Therapy Market Segmentation & Coverage
  • TABLE 2. Global Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 4. Global Accessories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Accessories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Accessories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Kits & Cartridges Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Kits & Cartridges Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Kits & Cartridges Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Culture Media Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Culture Media Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Culture Media Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Cytokines Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Cytokines Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Cytokines Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Growth Factors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Growth Factors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Growth Factors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Cell Expansion Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Cell Expansion Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Cell Expansion Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Cell Processing Workstations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Cell Processing Workstations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Cell Processing Workstations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Cell Selection Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Cell Selection Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Cell Selection Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Magnetic Bead Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Magnetic Bead Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Magnetic Bead Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Microfluidic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Microfluidic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Microfluidic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Cell Washing & Concentration Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Cell Washing & Concentration Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Cell Washing & Concentration Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Software Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 56. Global Dendritic Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Dendritic Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Dendritic Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global NK Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global NK Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global NK Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Stem Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Stem Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Stem Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global T Cells Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global T Cells Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global T Cells Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 69. Global Cell Expansion Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Cell Expansion Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Cell Expansion Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Cell Selection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Cell Selection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Cell Selection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Cryopreservation & Storage Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Cryopreservation & Storage Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Cryopreservation & Storage Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Formulation & Fill-Finish Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Formulation & Fill-Finish Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Formulation & Fill-Finish Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Washing & Concentration Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Washing & Concentration Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Washing & Concentration Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 85. Global Closed Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Global Closed Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. Global Closed Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 88. Global Open Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Global Open Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. Global Open Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 91. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 92. Global Allogeneic Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global Allogeneic Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global Allogeneic Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Autologous Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Autologous Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Autologous Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 99. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 100. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 101. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 102. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 104. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 105. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 108. Global Pharmaceutical & Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Global Pharmaceutical & Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. Global Pharmaceutical & Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 111. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 113. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 114. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 115. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 116. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 117. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 118. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 119. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 120. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 121. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 122. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 123. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 124. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 125. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 126. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 127. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 128. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 129. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 130. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 131. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 132. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 133. North America Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 134. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 135. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 136. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 137. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 138. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 139. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 140. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 141. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 142. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 143. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 144. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 145. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 146. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 147. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 148. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 149. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 150. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 151. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 152. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 153. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 154. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 155. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 157. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 158. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 159. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 160. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 161. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 162. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 163. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 164. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 165. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 166. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 167. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 168. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 169. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 170. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 171. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 172. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 173. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 174. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 175. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 176. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 177. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 178. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 180. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 181. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 182. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 183. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 184. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 185. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 186. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 187. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 188. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 189. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 190. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 191. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 192. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 193. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 194. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 195. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 196. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 197. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 198. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 199. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 201. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 202. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 203. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 204. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 205. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 206. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 207. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 208. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 209. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 210. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 211. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 212. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 213. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 214. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 215. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 216. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 217. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 218. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 219. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 220. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 221. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 222. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 223. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 224. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 225. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 226. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 227. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 228. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 229. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 230. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 231. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 232. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 233. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 234. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 235. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 236. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 237. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 238. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 239. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 240. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 241. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 242. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 243. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 244. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 246. United States Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 247. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 248. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 249. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 250. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 251. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 252. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 253. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 254. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 255. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 256. United States Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 257. Canada Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 258. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 259. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 260. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 261. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 262. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 263. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 264. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 265. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 266. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 267. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 268. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 269. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 270. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 271. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 272. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 273. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 274. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 275. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 276. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 277. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 278. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 279. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 280. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 281. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 282. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 283. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 284. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 285. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 286. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 287. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 288. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 289. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 290. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
  • TABLE 291. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
  • TABLE 292. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
  • TABLE 293. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
  • TABLE 294. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
  • TABLE 295. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
  • TABLE 296. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
  • TABLE 297. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
  • TABLE 298. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 299. United Kingdom Automated Cell Processing Syst